advancedPopularity: 76Epitalon: 10-20 day cycles 2-3x/year; Others: 4-12 week cycles

The Longevity Stack

Maximum Lifespan Extension

Anti-Aging & Longevity

Description

The most comprehensive longevity stack available, targeting the four pillars of aging: telomere shortening, mitochondrial dysfunction, metabolic decline, and cellular stress. Based on cutting-edge longevity research.

🔬 How It Works

Epitalon activates telomerase to maintain telomere length. SS-31 (Elamipretide) targets cardiolipin in the inner mitochondrial membrane, restoring mitochondrial function and reducing oxidative stress. Humanin is a mitochondrial-derived peptide that protects against cellular stress and apoptosis. MOTS-c activates AMPK and improves metabolic homeostasis. Together they address aging at the deepest cellular levels.

Synergy Explanation

This stack addresses aging's four horsemen: Epitalon fights telomere shortening (the cellular clock), SS-31 restores mitochondrial function (the cellular powerplant), Humanin protects against cellular stress and death signals, and MOTS-c optimizes metabolism (the cellular fuel system). By targeting all four pathways simultaneously, this stack aims for comprehensive protection against age-related decline.

🧬 Peptides in This Stack

SponsoredPartner with us — advertise hereContact us

Timing & Administration

Duration: Epitalon: 10-20 day cycles 2-3x/year; Others: 4-12 week cycles

Time of Day: Epitalon evening; SS-31 morning; Humanin and MOTS-c morning

Notes: This is a cutting-edge experimental protocol. Most of these peptides have limited human clinical data. Work with a longevity-focused physician and monitor biomarkers of aging.

Expected Results

  • Improved energy and vitality within 2-4 weeks
  • Better exercise capacity and recovery
  • Improved metabolic markers
  • Potential slowing of biological aging (measure with epigenetic clocks)
  • Enhanced cellular resilience to stress
  • Improved cardiovascular function

⚠️ Warnings & Precautions

  • Highly experimental — limited human clinical data for this combination
  • Work with a longevity-focused physician
  • Monitor comprehensive biomarkers regularly
  • SS-31 is still in clinical trials
  • Cost may be significant for all four peptides
  • Individual responses vary significantly

🔗 Related Stacks